A first-of-its-kind inhalable gene therapy for lung cancer that genetically modifies people’s lung cells has been fast-tracked towards potential approval after promising clinical trial results.
“Very encouragingly, the hypothesis was proven – that there was actually shrinkage of the tumours in the lungs,” Wen Wee Ma at Cleveland Clinic in Ohio told a recent meeting of the American Society of Clinical Oncology in Chicago.
A gene therapy that patients breathe in has been found to shrink lung tumours by inserting immune-boosting genes into surrounding cells https://t.co/dFHJ8yFptQ
— New Scientist (@newscientist) February 11, 2026
Leave a Reply
You must be logged in to post a comment.